|Pathology and genetics of tumours of haematopoietic and lymphoid tissues|
|Diagnostic criteria and classification of mastocytosis: a consensus proposal|
P Valent, HP Horny, L Escribano, BJ Longley, CY Li, LB Schwartz, ...
Leukemia research 25 (7), 603-625, 2001
|Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria|
P Valent, C Akin, L Escribano, M Födinger, K Hartmann, K Brockow, ...
European journal of clinical investigation 37 (6), 435-453, 2007
|KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA …|
AC Garcia-Montero, M Jara-Acevedo, C Teodosio, ML Sanchez, R Nunez, ...
Blood 108 (7), 2366-2372, 2006
|Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal|
P Valent, C Akin, M Arock, K Brockow, JH Butterfield, MC Carter, ...
International archives of allergy and immunology 157 (3), 215-225, 2012
|Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and …|
M Ocqueteau, A Orfao, J Almeida, J Blade, M Gonzalez, R García-Sanz, ...
The American journal of pathology 152 (6), 1655, 1998
|Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications|
L Escribano, A Orfao, B Dıaz-Agustin, J Villarrubia, C Cerveró, A López, ...
Blood, The Journal of the American Society of Hematology 91 (8), 2731-2736, 1998
|Mastocytosis: pathology, genetics, and current options for therapy|
P Valent, C Akin, W Sperr, M Mayerhofer, M Födinger, R Fritsche-Polanz, ...
Leukemia & lymphoma 46 (1), 35-48, 2005
|Recent advances in the understanding of mastocytosis: the role of KIT mutations*|
A Orfao, AC Garcia‐Montero, L Sanchez, L Escribano
British journal of haematology 138 (1), 12-30, 2007
|Mastocytosis: current concepts in diagnosis and treatment|
L Escribano, C Akin, M Castells, A Orfao, D Metcalfe
Annals of hematology 81 (12), 677-690, 2002
|Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients|
L Escribano, I Álvarez-Twose, L Sánchez-Muñoz, A Garcia-Montero, ...
Journal of Allergy and Clinical Immunology 124 (3), 514-521, 2009
|Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria|
P Valent, C Akin, WR Sperr, L Escribano, M Arock, HP Horny, JM Bennett, ...
Leukemia research 27 (7), 635-641, 2003
|One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes|
K Sotlar, L Escribano, O Landt, S Möhrle, S Herrero, A Torrelo, U Lass, ...
The American journal of pathology 162 (3), 737-746, 2003
|Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis|
WR Sperr, L Escribano, JH Jordan, GH Schernthaner, M Kundi, HP Horny, ...
Leukemia research 25 (7), 529-536, 2001
|Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma …|
K Hartmann, L Escribano, C Grattan, K Brockow, MC Carter, ...
Journal of Allergy and Clinical Immunology 137 (1), 35-45, 2016
|Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms|
I Álvarez-Twose, DG de Olano, L Sánchez-Muñoz, A Matito, ...
Journal of allergy and clinical immunology 125 (6), 1269-1278. e2, 2010
|Diagnosis and treatment of cutaneous mastocytosis in children|
M Castells, DD Metcalfe, L Escribano
American journal of clinical dermatology 12 (4), 259-270, 2011
|Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease|
WR Sperr, JH Jordan, M Fiegl, L Escribano, C Bellas, S Dirnhofer, ...
International archives of allergy and immunology 128 (2), 136-141, 2002
|Immunophenotypic analysis of Waldenstrom's macroglobulinemia|
JF San Miguel, MB Vidriales, E Ocio, G Mateo, F Sanchez-Guijo, ...
Seminars in oncology 30 (2), 187-195, 2003
|Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain.|
R Lopez-Velez, JA Perez-Molina, A Guerrero, F Baquero, J Villarrubia, ...
The American journal of tropical medicine and hygiene 58 (4), 436-443, 1998